TY - JOUR
T1 - Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients
AU - Kolstad, Josephine
AU - Zoppo, Christopher
AU - Johnston, Jean M.
AU - D'Souza, Precilla
AU - Kühn, Anna Luisa
AU - Vardar, Zeynep
AU - Peker, Ahmet
AU - Hader, Asma
AU - Celik, Hakki
AU - Lewis, Connor J.
AU - Lindsay, Clifford
AU - Rentiya, Zubir S.
AU - Lebel, Catherine
AU - Vedantham, Srinivasan
AU - Vachha, Behroze
AU - Gray-Edwards, Heather L.
AU - Acosta, Maria T.
AU - Tifft, Cynthia J.
AU - Shazeeb, Mohammed Salman
N1 - Publisher Copyright:
© 2025 Elsevier Inc.
PY - 2025/3
Y1 - 2025/3
N2 - Objective: GM1 gangliosidosis is a rare lysosomal storage disorder characterized by the accumulation of GM1 gangliosides in neuronal cells, resulting in severe neurodegeneration. Currently, limited data exists on the brain volumetric changes associated with this disease. This study focuses on the late-infantile and juvenile subtypes of type II GM1 gangliosidosis, aiming to quantify brain volumetric characteristics to track disease progression. Methods: Brain volumetric analysis was conducted on 56 MRI scans from 24 type II GM1 patients (8 late-infantile and 16 juvenile) and 19 healthy controls over multiple time points. The analysis included the use of semi-automated segmentation of the whole brain, ventricles, cerebellum, corpus callosum, thalamus, caudate, and lentiform nucleus. A generalized linear model was used to compare the volumetric measurements between the patient groups and healthy controls, accounting for age as a confounding factor. Results: Both late-infantile and juvenile GM1 patients exhibited significant whole-brain atrophy compared to healthy controls, even after adjusting for age. Notably, the late-infantile subtype displayed more pronounced atrophy in the cerebellum, thalamus, and corpus callosum compared to the juvenile subtype. Both late-infantile and juvenile subtypes showed significantly higher ventricular volumes and a significant reduction in all other structure volumes compared to the healthy controls. The volumetric measurements also correlated well with disease severity based on clinical metrics. Conclusions: The findings underscore the distinct brain volumetrics of the late-infantile and juvenile subtypes of GM1 gangliosidosis compared to healthy controls. These quantifications can be used as reliable imaging biomarkers to track disease progression and evaluate responses to therapeutic interventions.
AB - Objective: GM1 gangliosidosis is a rare lysosomal storage disorder characterized by the accumulation of GM1 gangliosides in neuronal cells, resulting in severe neurodegeneration. Currently, limited data exists on the brain volumetric changes associated with this disease. This study focuses on the late-infantile and juvenile subtypes of type II GM1 gangliosidosis, aiming to quantify brain volumetric characteristics to track disease progression. Methods: Brain volumetric analysis was conducted on 56 MRI scans from 24 type II GM1 patients (8 late-infantile and 16 juvenile) and 19 healthy controls over multiple time points. The analysis included the use of semi-automated segmentation of the whole brain, ventricles, cerebellum, corpus callosum, thalamus, caudate, and lentiform nucleus. A generalized linear model was used to compare the volumetric measurements between the patient groups and healthy controls, accounting for age as a confounding factor. Results: Both late-infantile and juvenile GM1 patients exhibited significant whole-brain atrophy compared to healthy controls, even after adjusting for age. Notably, the late-infantile subtype displayed more pronounced atrophy in the cerebellum, thalamus, and corpus callosum compared to the juvenile subtype. Both late-infantile and juvenile subtypes showed significantly higher ventricular volumes and a significant reduction in all other structure volumes compared to the healthy controls. The volumetric measurements also correlated well with disease severity based on clinical metrics. Conclusions: The findings underscore the distinct brain volumetrics of the late-infantile and juvenile subtypes of GM1 gangliosidosis compared to healthy controls. These quantifications can be used as reliable imaging biomarkers to track disease progression and evaluate responses to therapeutic interventions.
KW - Brain
KW - GM1 gangliosidosis
KW - MRI
KW - Volumetrics
UR - http://www.scopus.com/inward/record.url?scp=85215943073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85215943073&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2025.109025
DO - 10.1016/j.ymgme.2025.109025
M3 - Article
AN - SCOPUS:85215943073
SN - 1096-7192
VL - 144
JO - Molecular Genetics and Metabolism
JF - Molecular Genetics and Metabolism
IS - 3
M1 - 109025
ER -